Search Results

There are 144849 results for: content related to: A Woman with Breast Cancer and Severe Impaired Lactose Tolerance: An Intriguing Therapeutic Dilemma

  1. Fulvestrant in Advanced Breast Cancer Following Tamoxifen and Aromatase Inhibition: A Single Center Experience

    The Breast Journal

    Volume 15, Issue 3, May/June 2009, Pages: 247–253, Jayson Wang, Sandeep Jain, Charles R. Coombes and Carlo Palmieri

    Article first published online : 5 MAY 2009, DOI: 10.1111/j.1524-4741.2009.00713.x

  2. You have full text access to this OnlineOpen article
    Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsies

    International Journal of Cancer

    Volume 138, Issue 1, 1 January 2016, Pages: 146–159, Amit Agrawal, John F.R. Robertson, Kwok L. Cheung, Eleanor Gutteridge, Ian O. Ellis, Robert I. Nicholson and Julia M.W. Gee

    Article first published online : 30 JUL 2015, DOI: 10.1002/ijc.29682

  3. Metastatic breast cancer: sequencing hormonal therapy and positioning of fulvestrant

    International Journal of Gynecological Cancer

    Volume 16, Issue s2, September 2006, Pages: 524–526, I. VERGOTE, F. AMANT, K. LEUNEN, T. VAN GORP, P. BERTELOOT and P. NEVEN

    Article first published online : 26 SEP 2006, DOI: 10.1111/j.1525-1438.2006.00687.x

  4. You have full text access to this Open Access content
    mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels

    Cancer Science

    Volume 99, Issue 10, October 2008, Pages: 1992–2003, Sandra E. Ghayad, Ivan Bieche, Julie A. Vendrell, Celine Keime, Rosette Lidereau, Charles Dumontet and Pascale A. Cohen

    Article first published online : 14 OCT 2008, DOI: 10.1111/j.1349-7006.2008.00955.x

  5. You have free access to this content
    Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women

    Cancer

    Volume 98, Issue 2, 15 July 2003, Pages: 229–238, John F. R. Robertson, C. Kent Osborne, Anthony Howell, Stephen E. Jones, Louis Mauriac, Matthew Ellis, Ulrich R. Kleeberg, Steven E. Come, Ignace Vergote, Stan Gertler, Aman Buzdar, Alan Webster and Charles Morris

    Article first published online : 2 JUN 2003, DOI: 10.1002/cncr.11468

  6. Oral Metronomic Cyclophosphamide and Methotrexate Plus Fulvestrant in Advanced Breast Cancer Patients: A Mono-Institutional Case-Cohort Report

    The Breast Journal

    Volume 18, Issue 5, September/October 2012, Pages: 470–474, Gaetano Aurilio, Elisabetta Munzone, Edoardo Botteri, Angela Sciandivasci, Laura Adamoli, Ida Minchella, Angela Esposito, Daniela Cullurà, Giuseppe Curigliano, Marco Colleoni, Aron Goldhirsch and Franco Nolè

    Article first published online : 25 JUL 2012, DOI: 10.1111/j.1524-4741.2012.01278.x

  7. Effect of the oestrogen receptor antagonist fulvestrant on the cirrhotic rat lung

    Fundamental & Clinical Pharmacology

    Volume 29, Issue 3, June 2015, Pages: 269–277, Monique Oswald-Mammosser, Sherzad Rashid, Nelly Boehm, Arnaud Agin, Bernard Geny, Valérie Schini-Kerth and Anne Charloux

    Article first published online : 6 APR 2015, DOI: 10.1111/fcp.12114

  8. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

    Intervention Review

    The Cochrane Library

    Lorna Gibson, David Lawrence, Claire Dawson and Judith Bliss

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD003370.pub3

  9. You have free access to this content
    Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 241–247, Antonio Llombart-Cussac, Amparo Ruiz, Antonio Antón, Agustí Barnadas, Silvia Antolín, José E. Alés-Martínez, Isabel Álvarez, Raquel Andrés, José A. García Saenz, Juan Lao, Eva Carrasco, Carmen Cámara, Isabel Casas and Miguel Martín

    Article first published online : 29 JUN 2011, DOI: 10.1002/cncr.26299

  10. Estrogen Enhances Activity of Wnt Signaling During Osteogenesis by Inducing Fhl1 Expression

    Journal of Cellular Biochemistry

    Volume 116, Issue 7, July 2015, Pages: 1419–1430, Shao-Min Wu, Lan-Hsin Shih, Jing-Yu Lee, Yi-Jun Shen and Hu-Hui Lee

    Article first published online : 12 MAY 2015, DOI: 10.1002/jcb.25102

  11. You have free access to this content
    Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma

    Cancer

    Volume 104, Issue 2, 15 July 2005, Pages: 236–239, Anthony Howell, John Pippen, Richard M. Elledge, Louis Mauriac, Ignace Vergote, Stephen E. Jones, Steven E. Come, C. Kent Osborne and John F.R. Robertson

    Article first published online : 3 JUN 2005, DOI: 10.1002/cncr.21163

  12. You have free access to this content
    Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways

    International Journal of Cancer

    Volume 126, Issue 2, 15 January 2010, Pages: 545–562, Sandra E. Ghayad, Julie A. Vendrell, Sabrina Ben Larbi, Charles Dumontet, Ivan Bieche and Pascale A. Cohen

    Article first published online : 16 JUL 2009, DOI: 10.1002/ijc.24750

  13. Is fulvestrant (“Faslodex”) just another selective estrogen receptor modulator?

    International Journal of Gynecological Cancer

    Volume 16, Issue s2, September 2006, Pages: 521–523, A. HOWELL

    Article first published online : 26 SEP 2006, DOI: 10.1111/j.1525-1438.2006.00686.x

  14. Sensitive and rapid high-performance liquid chromatography tandem mass spectrometry method for estimation of fulvestrant in rabbit plasma

    Biomedical Chromatography

    Volume 24, Issue 8, August 2010, Pages: 863–867, Varanasi Murali Balaram, Dharmesh Parmar, Bulusu B Teja, Shivprakash Rathnam, Jangala Venkateswara Rao and Bhavesh Dasandi

    Article first published online : 10 JAN 2010, DOI: 10.1002/bmc.1378

  15. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies

    British Journal of Dermatology

    Volume 158, Issue 1, January 2008, Pages: 109–115, J. Gassmueller, R. Hoffmann and A. Webster

    Article first published online : 6 NOV 2007, DOI: 10.1111/j.1365-2133.2007.08276.x

  16. You have free access to this content
    Effects of the oestrogen receptor antagonist Fulvestrant on expression of genes that affect organization of the epididymal epithelium

    Andrology

    Volume 2, Issue 4, July 2014, Pages: 559–571, M. F. N. Pereira, S. A. F. Fernandes, A. R. Nascimento, E. R. Siu, R. A. Hess, C. A. Oliveira, C. S. Porto and M. F. M. Lazari

    Article first published online : 30 APR 2014, DOI: 10.1111/j.2047-2927.2014.00219.x

  17. Endocrine Treatment and Prevention of Breast and Gynecological Cancers Vth International Symposium of the Flemish Gynecological Oncology Group, January 26–28, 2006

    International Journal of Gynecological Cancer

    Volume 16, Issue s2, September 2006, Pages: 479–491, P. NEVEN, I. VERGOTE, F. AMANT, P. BERTELOOT, E. De JONGE, C. DE ROP, P. DE SUTTER, A. MAKAR and J. VAN GINDERACHTER

    Article first published online : 26 SEP 2006, DOI: 10.1111/j.1525-1438.2006.00673.x

  18. Overcoming resistance to fulvestrant (ICI182,780) by Downregulating the c-ABL Proto-Oncogene in breast cancer

    Molecular Carcinogenesis

    Volume 50, Issue 5, May 2011, Pages: 383–389, Huajun Zhao, Yuan-Hung Lo, Ling Yu and Shao-Chun Wang

    Article first published online : 28 DEC 2010, DOI: 10.1002/mc.20721

  19. Phase II study of fulvestrant (faslodex®) in castration resistant prostate cancer

    The Prostate

    Volume 68, Issue 13, 15 September 2008, Pages: 1461–1466, Manpreet K. Chadha, Umeer Ashraf, David Lawrence, Lili Tian, Ellis Levine, Carrie Silliman, Paul Escott, Valencia Payne and Donald L. Trump

    Article first published online : 10 JUL 2008, DOI: 10.1002/pros.20813

  20. You have free access to this content
    Rational management of endocrine resistance in breast cancer

    Cancer

    Volume 113, Issue 9, 1 November 2008, Pages: 2385–2397, Sara A. Hurvitz and Richard J. Pietras

    Article first published online : 26 SEP 2008, DOI: 10.1002/cncr.23875